Open Menu
Companies>BlueRock Therapeutics
Last Modified13/08/2025 5:16 PM
cover
BlueRock Therapeutics icon

BlueRock Therapeutics

Claimed Company
Employee Participants180
Total Rating5,197
Revenue$0
BlueRock Therapeutics Culture This score is derived from employee ratings & reviews
Choice Employer
4.7/5
BlueRock Therapeutics's Overall Culture is rated
A+

BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves. Read More

Headquarters 238 Main Street, Cambridge, MA 02142, USA